BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 4128922)

  • 1. [Hepatotoxicity of rifampicin-rifamycin SV in the treatment of tuberculous meningitis (author's transl)].
    Ziebart-Schroth A
    Wien Klin Wochenschr; 1973 Oct; 85(42):692-5. PubMed ID: 4128922
    [No Abstract]   [Full Text] [Related]  

  • 2. [Hepatotoxicity of rifampicin and isoniazid in the treatment of tuberculous meningitis (author's transl)].
    Frontera Izquierdo P; Unceta Aguirre L; Tomás Vila M; Calvo Rigual F; Pérez Tamarit D
    An Esp Pediatr; 1981 Dec; 15(6):549-52. PubMed ID: 7337308
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [The results of liver biopsies during rifampicin therapy (author's transl)].
    Kozma D; Lapis K; Tompa A
    Prax Pneumol; 1976 Dec; 30(12):764-70. PubMed ID: 1013060
    [No Abstract]   [Full Text] [Related]  

  • 4. [Liver toxicity of combined rifampicin-isoniazid-ethambutol medication (author's transl)].
    Austerhoff A; Kindler U; Knop P; Knieriem HJ
    Dtsch Med Wochenschr; 1974 May; 99(22):1182 p. PubMed ID: 4835559
    [No Abstract]   [Full Text] [Related]  

  • 5. [Hepatoxic effects of rifampicin].
    Lechner HJ; Reimers D
    Prax Pneumol; 1973 Apr; 27(4):241-9. PubMed ID: 4698443
    [No Abstract]   [Full Text] [Related]  

  • 6. Methyldopa-induced submassive hepatic necrosis.
    Rehman OU; Keith TA; Gall EA
    JAMA; 1973 Jun; 224(10):1390-2. PubMed ID: 4739987
    [No Abstract]   [Full Text] [Related]  

  • 7. [Cholestatic hepatitis during treatment with I.N.H. and rifampicin: arguments in favour of the hepatotoxicity of rifampicin (author's transl)].
    Poupon RY; Meyniel D; Petit J; Gustot P; Darnis F
    Ann Med Interne (Paris); 1979; 130(6-7):371-5. PubMed ID: 496138
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [The influence of rifampicin upon the metabolism of isoniazid (author's transl)].
    Modai J; Coulaud JP; Vivien JM; Berthelot G; Bergogne-Berezin E
    Nouv Presse Med; 1978 Apr; 7(15):1263-7. PubMed ID: 662655
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Rifampicin. Study of its antitubercular effect and its hepatic tolerance in 200 patients].
    Macquet V; Lafitte P; Rogeaux Y
    Lille Med; 1972 May; 17(5):755-61. PubMed ID: 5056293
    [No Abstract]   [Full Text] [Related]  

  • 10. [Frequency, diagnosis, and course of hepatotoxic side effects of Rifampicin (author's transl)].
    Deck KA; Gehrhardt A; Klein HO; Ludes H
    Med Klin; 1976 Oct; 71(43):1836-41. PubMed ID: 995024
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Hydrazide-rifampicin: hepatotoxicity in children].
    Uriz Urzainqui S; Masvidal Aliberch RM; Sabriá Pau J; Bofill Bernaldo AM
    An Esp Pediatr; 1981 Oct; 15(4):401-3. PubMed ID: 7337305
    [No Abstract]   [Full Text] [Related]  

  • 12. Predisposing factors in hepatitis induced by isoniazid-rifampin treatment of tuberculosis.
    Grönhagen-Riska C; Hellstrom PE; Fröseth B
    Am Rev Respir Dis; 1978 Sep; 118(3):461-6. PubMed ID: 707874
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pharmacokinetics and safety/tolerability of higher oral and intravenous doses of rifampicin in adult tuberculous meningitis patients.
    Yunivita V; Dian S; Ganiem AR; Hayati E; Hanggono Achmad T; Purnama Dewi A; Teulen M; Meijerhof-Jager P; van Crevel R; Aarnoutse R; Ruslami R
    Int J Antimicrob Agents; 2016 Oct; 48(4):415-21. PubMed ID: 27526979
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Hormonal contraceptives and liver damages].
    Otto G; Uhlig K
    Z Arztl Fortbild (Jena); 1974 Nov; 68(21):1181-3. PubMed ID: 4456840
    [No Abstract]   [Full Text] [Related]  

  • 15. [Therapy of tuberculosis with Rifampicin in childhood (author's transl)].
    Simon K
    Med Klin; 1975 Jun; 70(25):1095-7. PubMed ID: 1083476
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Hepatic damage in patients treated with rifampicin (author's transl)].
    Entz A; Kozma D; Vincze E; Balázs M; Vámos K
    Pneumonologie; 1974 Sep; 151(1):41-54. PubMed ID: 4216011
    [No Abstract]   [Full Text] [Related]  

  • 17. [Liver toxicity of aetina and pyracinamide and their control by determination of LAP activity in blood serum].
    Matzel W; Lindemann I
    Z Erkr Atmungsorgane Folia Bronchol; 1969; 131(1):87-98. PubMed ID: 5197904
    [No Abstract]   [Full Text] [Related]  

  • 18. [Glutamic-pyruvic transaminase and glutamic-oxaloacetic transaminase in the cerebrospinal fluid in children with tuberculous encephalomeningitis].
    Kalinowska B; Nawarecki B
    Gruzlica; 1966 Feb; 34(2):145-6. PubMed ID: 5944788
    [No Abstract]   [Full Text] [Related]  

  • 19. Hepatotoxicity of papaverine.
    Kiaer HW; Olsen S; Ronnov-Jessen V
    Arch Pathol; 1974 Nov; 98(5):292-6. PubMed ID: 4413667
    [No Abstract]   [Full Text] [Related]  

  • 20. [Liver dysfunction induced by rifampicin (author's transl)].
    Kutsukake F; Murakami T; Sasaki Y; Mitani Y; Kamada T; Shigeto N; Yoshioka H; Sewake N; Fukuhara N; Shibata Y; Shigeto E; Tanaka K; Kadosawa K; Kou E; Mochizuki K
    Kekkaku; 1982 Apr; 57(4):257-61. PubMed ID: 7109426
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.